MedTrace Logo

A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care

NCT02487888 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100000

Last updated 2016-03-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of genetic testing on healthcare decisions and patient outcomes for patients suffering from pain, cardiovascular problems, Arthritis, Type II Diabetes, and/or Mental Health disorders. Results of genetic testing will also be compared with the clinical outcome measures collected to discover novel genetic factors that may influence patient care.

Conditions

Interventions

OTHER

Unblinded to Genetic Testing Results

The physicians of this group of patients will be unblinded to the results of the genetic testing.

OTHER

Blinded to Genetic Testing Results

The physicians of this group of patients will be blinded to the results of the genetic testing. They will be un-blinded to the results of each patient once that patient has completed the study.

Sponsors & Collaborators

  • Proove Bioscience, Inc.

    lead INDUSTRY

Principal Investigators

  • Gregory A Smith, M.D. · G.S. Medical Center Inc./Comprehensive Pain Relief Group

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-10-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02487888 on ClinicalTrials.gov